microdosing glp-1 oral GLP-1 Microdosing – Kora MD

Current pharmacologic therapy includes inhaled corticosteroids (ICS)/formoterol as required (PRN) or regular low dose ICS stepping up to combination inhaled steroids and long acting beta agonists (ICS/LABA) with additional therapies including leukotriene receptor antagonists (LTRA) or long acting anti-muscarinic agents (LAMA) to biologics, all on top of reliever therapies which can be a beta agonist or an ICS/Formoterol combination

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analyses were performed using a Waters XEVO TQS system (Waters, Eschborn, Germany) equipped with an electrospray ion source

Monograph: Bacteriostatic Water for Injection

Collectively, the evidence suggests that optimising meal timing (avoiding intake close to bedtime) alongside maintaining regular daytime meals may represent pragmatic, modifiable targets to support sleep health, although causal relationships remain to be confirmed

Where to begin